Ex vivo detection of SARS-CoV-2-specific CD8+ T cells: rapid induction, prolonged contraction, and formation of functional memory
By
Isabel Schulien,
Janine Kemming,
Valerie Oberhardt,
Katharina Wild,
Lea M. Seidel,
Saskia Killmer,
Sagar,
Franziska Daul,
Marilyn Salvat Lago,
Annegrit Decker,
Hendrik Luxenburger,
Benedikt Binder,
Dominik Bettinger,
Oezlem Sogukpinar,
Siegbert Rieg,
Marcus Panning,
Daniela Huzly,
Martin Schwemmle,
Georg Kochs,
Cornelius F. Waller,
Alexandra Nieters,
Daniel Duerschmied,
Florian Emmerich,
Henrik Mei,
Axel Schulz,
Sian Llewellyn-Lacey,
David A. Price,
Tobias Boettler,
Bertram Bengsch,
Robert Thimme,
Maike Hofmann,
Christoph Neumann-Haefelin
Posted 14 Aug 2020
bioRxiv DOI: 10.1101/2020.08.13.249433
CD8+ T cells are critical for the elimination and long-lasting protection of many viral infections, but their role in the current SARS-CoV-2 pandemic is unclear. Emerging data indicates that SARS-CoV-2-specific CD8+ T cells are detectable in the majority of individuals recovering from SARS-CoV-2 infection. However, optimal virus-specific epitopes, the role of pre-existing heterologous immunity as well as their kinetics and differentiation program during disease control have not been defined in detail. Here, we show that both pre-existing and newly induced SARS-CoV-2-specific CD8+ T-cell responses are potentially important determinants of immune protection in mild SARS-CoV-2 infection. In particular, our results can be summarized as follows: First, immunodominant SARS-CoV-2-specific CD8+ T-cell epitopes are targeted in the majority of individuals with convalescent SARS-CoV-2 infection. Second, MHC class I tetramer analyses revealed the emergence of phenotypically diverse and functionally competent pre-existing and newly induced SARS-CoV-2-specific memory CD8+ T cells that showed similar characteristics compared to influenza-specific CD8+ T cells. Third, SARS-CoV-2-specific CD8+ T-cell responses are more robustly detectable than antibodies against the SARS-CoV-2-spike protein. This was confirmed in a longitudinal analysis of acute-resolving infection that demonstrated rapid induction of the SARS-CoV-2-specific CD8+ T cells within a week followed by a prolonged contraction phase that outlasted the waning humoral immune response indicating that CD8+ T-cell responses might serve as a more precise correlate of antiviral immunity than antibody measurements after convalescence. Collectively, these data provide new insights into the fine specificity, heterogeneity, and dynamics of SARS-CoV-2-specific memory CD8+ T cells, potentially informing the rational development of a protective vaccine against SARS-CoV-2. ### Competing Interest Statement The authors have declared no competing interest.
Download data
- Downloaded 1,745 times
- Download rankings, all-time:
- Site-wide: 8,572
- In immunology: 234
- Year to date:
- Site-wide: 11,206
- Since beginning of last month:
- Site-wide: 14,777
Altmetric data
Downloads over time
Distribution of downloads per paper, site-wide
PanLingua
News
- 27 Nov 2020: The website and API now include results pulled from medRxiv as well as bioRxiv.
- 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
- 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
- 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
- 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
- 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
- 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
- 22 Jan 2019: Nature just published an article about Rxivist and our data.
- 13 Jan 2019: The Rxivist preprint is live!